GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Gross Margin %

BLIS Technologies (NZSE:BLT) Gross Margin % : 79.21% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. BLIS Technologies's Gross Profit for the six months ended in Mar. 2024 was NZ$4.90 Mil. BLIS Technologies's Revenue for the six months ended in Mar. 2024 was NZ$6.19 Mil. Therefore, BLIS Technologies's Gross Margin % for the quarter that ended in Mar. 2024 was 79.21%.


The historical rank and industry rank for BLIS Technologies's Gross Margin % or its related term are showing as below:

NZSE:BLT' s Gross Margin % Range Over the Past 10 Years
Min: 71.59   Med: 78.07   Max: 81.8
Current: 76.88


During the past 13 years, the highest Gross Margin % of BLIS Technologies was 81.80%. The lowest was 71.59%. And the median was 78.07%.

NZSE:BLT's Gross Margin % is ranked better than
70.89% of 749 companies
in the Biotechnology industry
Industry Median: 60.63 vs NZSE:BLT: 76.88

BLIS Technologies had a gross margin of 79.21% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for BLIS Technologies was 1.60% per year.


BLIS Technologies Gross Margin % Historical Data

The historical data trend for BLIS Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Gross Margin % Chart

BLIS Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.66 81.80 78.12 78.01 78.54

BLIS Technologies Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.45 80.20 76.36 77.57 79.21

Competitive Comparison of BLIS Technologies's Gross Margin %

For the Biotechnology subindustry, BLIS Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BLIS Technologies's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Gross Margin % falls into.



BLIS Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

BLIS Technologies's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=8.2 / 10.484
=(Revenue - Cost of Goods Sold) / Revenue
=(10.484 - 2.25) / 10.484
=78.54 %

BLIS Technologies's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=4.9 / 6.19
=(Revenue - Cost of Goods Sold) / Revenue
=(6.19 - 1.287) / 6.19
=79.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BLIS Technologies  (NZSE:BLT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BLIS Technologies had a gross margin of 79.21% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


BLIS Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BLIS Technologies (NZSE:BLT) Business Description

Traded in Other Exchanges
N/A
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies (NZSE:BLT) Headlines

From GuruFocus

John Rogers Exits Blount International in 1st Quarter

By David Goodloe David Goodloe 06-12-2016

John Rogers Trims Stake in Blount International

By Kyle Ferguson Kyle Ferguson 04-18-2016

Blount International Inc. (BLT) CEO Joshua L Collins buys 5,000 Shares

By GuruFocus Research GuruFocus Editor 06-17-2010

Bill Nygren's Oakmark Comments on Blount International

By Holly LaFon Holly LaFon 07-10-2012

Blount International Inc. (BLT) CEO International Inc Blount buys 10,000 Shares

By GuruFocus Research GuruFocus Editor 10-01-2009